
|Articles|April 16, 2020
Accelerated Enrollment Solutions Launches Patient-Transfer Program to Support Trial Continuity During COVID-19 Pandemic
Advertisement
Accelerated Enrollment Solutions (AES) has launched a program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemicby transferring clinical trial patients to AES’ dedicated research sites from other research facilities.
To find out more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement